Posts

"Alcyone's Alivio Ventricular System, is comprised of a Flusher and Ventricular Catheter with unique relief membrane. The system, in conjunction with any CSF shunt, is designed to address one of the two most common problems with CSF shunts" https://www.prnewswire.com/news-releases/alcyone-lifesciences-receives-eu-ce-mark-approval-for-alivio-ventricular-catheter-and-flusher-system-for-treatment-of-hydrocephalus-300541763.html
Looks like an insightful read:  "Have we ever thought how neurosurgeons feel during or after surgeries"? http://ow.ly/NgKK30fKEWt
"A doctor called to tell her that her newborn daughter, Isabella, had hydrocephalus, the buildup of fluid in the brain. The 2-month-old had fought for her life from bacterial meningitis and wasn't expected to live" http://www.gazettenet.com/Teen-girl-battles-incurable-brain-condition-12866643
The video of Representative Howell (Michigan House of Representatives) recognizing September as hydrocephalus awareness month! We apologize for the rough edit and the low volume of Representative Howell.  September might be over, but as most of our fans know, we fight hydrocephalus every day of the year! #Hydrocephalus #PHF https://youtu.be/qQAbsybgEDc
I don't care so much about the stock, but the technology they are researching.  "Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures" https://topchronicle.com/digging-into-the-data-microbot-medical-inc-nasdaqmbot/
Very early in development but interesting to say the least (animation in link) "While it's still early in the development of this technology, we believe it has the potential to transform the treatment of patients who deal with the shortcomings of our current, 60-year-old open surgical approach," http://cerevasc.com/treatment-of-hydrocephalus/
  "PV (Programmable Shunt Valves) treatment is safe and may reduce the revision rate and over- or under-drainage complication rate, especially in patients aged less than 18 years with hydrocephalus. PV treatment is not associated with decreased overall complication rates in  patients with hydrocephalus , but the trial sequential analysis indicate more studies are needed to confirm this result." –International Journal of Surgery V44, 8/2017, pages 139-146 International Journal of Surgery Volume 44 , August 2017, Pages 139-146     http://www.sciencedirect.com/science/article/pii/S1743919117305411   Sent from my iPhone